Roger K.C. Ngan

Concurrent Chemotherapy-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma: Progression-Free Survival Analysis of a Phase III Randomized Trial

Anthony T.�C. Chan, P. Teo, Roger K.C. Ngan et al. · Journal of Clinical Oncology · 2002 · 482 citations

Treatment outcomes of nasopharyngeal carcinoma in modern era after intensity modulated radiotherapy (IMRT) in Hong Kong: A report of 3328 patients (HKNPCSG 1301 study)

Kwok‐Hung Au, Roger K.C. Ngan, Alice Ng et al. · Oral Oncology · 2017 · 280 citations

Hknpcsg 1301, Radiation Therapy, Medicine +9

Identification of Serum Amyloid A Protein As a Potentially Useful Biomarker to Monitor Relapse of Nasopharyngeal Cancer by Serum Proteomic Profiling

William C. Cho, Timothy T. C. Yip, Christine Yip et al. · Clinical Cancer Research · 2004 · 207 citations · Full text

Survival outcome of patients with nasopharyngeal carcinoma with first local failure: A study by the Hong Kong Nasopharyngeal Carcinoma Study Group

Kwok Hung Yu, Sing Fai Leung, Stewart Y. Tung et al. · Head & Neck · 2005 · 176 citations · Full text

Preliminary results of trial NPC‐0501 evaluating the therapeutic gain by changing from concurrent‐adjuvant to induction‐concurrent chemoradiotherapy, changing from fluorouracil to capecitabine, and changing from conventional to accelerated radiotherapy fractionation in patients with locoregionally advanced nasopharyngeal carcinoma

Anne W.M. Lee, Roger K.C. Ngan, Stewart Y. Tung et al. · Cancer · 2014 · 167 citations